NASDAQ: KROS
Keros Therapeutics Inc Stock Ownership - Who owns Keros Therapeutics?

Insider buying vs selling

Have Keros Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Adar1 Capital Management LLC10% Owner2025-06-20100$60.00
$6.00kSell
Adar1 Capital Management LLC10% Owner2025-06-201,400$70.00
$98.00kSell
Adar1 Capital Management LLC10% Owner2025-06-20200$70.00
$14.00kSell
Adar1 Capital Management LLC10% Owner2025-04-09500,000$10.33
$5.17MBuy
Adar1 Capital Management LLC10% Owner2025-04-0974,333$10.33
$767.86kBuy
Adar1 Capital Management LLC10% Owner2025-04-0918,560$9.40
$174.37kBuy
Adar1 Capital Management LLC10% Owner2025-04-0916,365$9.40
$153.75kBuy
Adar1 Capital Management LLC10% Owner2025-04-09325,000$9.86
$3.20MBuy
Jasbir SeehraCHIEF EXECUTIVE OFFICER2025-04-0449,367$0.30
$14.81kBuy
Carl L. GordonDirector2024-08-1329,400$44.01
$1.29MSell

1 of 2

KROS insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when KROS insiders and whales buy or sell their stock.

KROS Shareholders

What type of owners hold Keros Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Adar1 Capital Management LLC13.27%5,389,264$72.49MInsider
Nuveen LLC9.72%3,947,455$53.09MInstitution
Blackrock Inc6.86%2,785,237$37.46MInstitution
Jpmorgan Chase Co6.40%2,600,457$34.98MInstitution
Vanguard Group Inc6.32%2,566,321$34.52MInstitution
Alon Lazarus5.01%2,036,140$27.39MInsider
Arkin Bio Ventures Limited Partnership4.96%2,013,102$27.08MInsider
Logos Global Management LP4.92%2,000,000$26.90MInstitution
Morgan Stanley4.18%1,697,557$22.83MInstitution
Nantahala Capital Management LLC3.71%1,506,790$20.27MInstitution

1 of 3

KROS vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
KROS72.02%27.98%Net BuyingNet Buying
MNMD47.86%52.14%Net SellingNet Selling
ATAI10.93%36.61%Net Buying
TBPH50.90%49.10%Net BuyingNet Selling
ZVRA64.83%22.73%Net SellingNet Selling

Keros Therapeutics Stock Ownership FAQ

Who owns Keros Therapeutics?

Keros Therapeutics (NASDAQ: KROS) is owned by 90.46% institutional shareholders, 35.15% Keros Therapeutics insiders, and 0.00% retail investors. Adar1 Capital Management LLC is the largest individual Keros Therapeutics shareholder, owning 5.39M shares representing 13.27% of the company. Adar1 Capital Management LLC's Keros Therapeutics shares are currently valued at $72.49M.

If you're new to stock investing, here's how to buy Keros Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.